Immunotherapy dose reduced by a million

The NanoGhost cancer treatment targeted delivery mechanism developed by scientists at Israel’s Technion Institute is truly revolutionary (see here previously).  It enables the dose of existing immunotherapies (e.g., TRAIL) to be reduced by a millionfold, to prevent toxic side effects.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.